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Abstract
Objective
To synthesize existing qualitative literature on patient-experienced burden of treatment in
multimorbid patients.
Methods
A literature search identified available qualitative studies on the topic of burden of treatment
in multimorbidity and meta-ethnography was applied as method. The authors’ original find-
ings were preserved, but also synthesized to new interpretations to investigate the concept
of the burden of treatment using the Cumulative Complexity Model.
Results
Nine qualitative studies were identified. The majority of the 1367 participants from 34 differ-
ent countries were multimorbid. The treatment burden components, experienced by
patients, were identified for each study. The components financial burden, lack of knowl-
edge, diet and exercise, medication burden and frequent healthcare reminding patients of
their health problem were found to attract additional attention from the multimorbid patients.
In studies conducted in the US and Australia the financial burden and the time and travel
burden were found most straining to patients with deprived socioeconomic status.
The burden of treatment was found to be a complex concept consisting of many different
components and factors interacting with each other. The size of the burden was associated
to the workload of demands (number of conditions, number of medications and health sta-
tus), the capacity (cognitive, physical and financial resources, educational level, cultural
background, age, gender and employment conditions) and the context (structure of health-
care and social support).
Patients seem to use strategies such as prioritizing between treatments to diminish the
workload and mobilizing and coordinating resources to improve their ability to manage the
burden of treatment. They try to routinize and integrate the treatment into their daily lives,
which might be a way to maintain the balance between workload and capacity.
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Conclusions
Healthcare providers need to increase the focus on minimizing multimorbid patients’ burden
of treatment. Findings in this review suggest that the weight of the burden needs to be estab-
lished in the individual patient and components of the burden must be identified.
Introduction
Half of the adult population have chronic conditions[1], and as the treatment for chronic con-
ditions has improved, the life expectancy has increased and continues to do so[2]. As a result
multimorbidity, the co-existence of two or more chronic conditions, has emerged as a new
major health concern.
A review investigating the definition of multimorbidity in the scientific literature showed
that while diseases were included in all definitions, risk factors were often (87%) and symp-
toms less often (62%) included[3]. Exactly which diseases, risk factors and symptoms to
include in the definition is up for debate, and that partly explains why a review including
studies with different definitions of multimorbidity from countries all over the world shows
prevalences between 12,9% and 95,1%. However, the review does show that the main part of
prevalences are above 20%, increasing with age[4].
A cross-sectional study conducted in Scotland in 2012 found multimorbidity to be associ-
ated with socioeconomic status as the onset of multimorbidity occurred 10–15 years earlier in
people living in the most deprived areas compared with the most affluent[5].
The increasing prevalence of multimorbidity has several adverse consequences. Multimor-
bidity is known to result in a decreased quality of life[6], a higher mortality rate[7] and
increased healthcare utilization and cost in primary and secondary care[8]. Patients who have
chronic conditions and multimorbidity experience a variety of symptoms, but in addition to
this burden of illness, they are also affected by the burden of treatment (BoT). The BoT has
only recently started attracting attention and includes the challenges of everything patients do
to manage their conditions. It has been suggested that patients suffering from multimorbidity
and an excessive BoT might not adhere to prescribed medical treatment [9, 10]. This may in
some cases pose a problem since poor adherence to certain evidence-based pharmacotherapy
is known to lead to greater risk of hospitalization and mortality[11, 12].
The Cumulative Complexity Model
Several different models and theories have been used to describe the BoT[13–15]. Shippee
et al. created in 2012 the Cumulative Complexity Model[13] by conducting a narrative litera-
ture review. The model states that clinical and social factors accumulate and add to a certain
workload on the patient, balanced by the capacity (cognitive, physical and financial resources)
of the patient. This balance results in healthcare access, utilization and self-care, which loops
back and affects the workload and capacity. All of the above mentioned factors might have an
impact on the health outcome of the patient. If a worsened health outcome encourages the
healthcare provider to adjust the treatment and increase the size of the BoT, this might loop
back and affect workload and capacity with risk of creating a vicious circle. The model will be
used for understanding findings in this review.
As accounted for, the BoT poses an increasing problem in multimorbid patients and a
deeper understanding of the BoT is needed. Several qualitative studies addressing the BoT
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from the perspective of patients with multimorbidity have been conducted. A review synthe-
sizing these studies will provide a broader image of the BoT and until now, no such review has
been conducted. Therefore, the purpose of this paper is to investigate the BoT in multimorbid
patients by systematically reviewing empirical qualitative research to answer following
questions:
Research questions
1. Which components form the burden of treatment in the view of patients with
multimorbidity?
2. Which components attract additional attention from the multimorbid patients?
3. How is the patient-experienced burden of treatment in patients with multimorbidity con-
ceptualized in the included studies?
Methods and material
Meta-ethnography developed by Noblit and Hare[16] is a method of seven steps to synthesize
qualitative data. It has been suggested that meta-ethnography is particularly suitable when
looking at individuals’ experiences[17], and the method has been successfully used in other
reviews to understand medicine-taking and patients’ experience of diabetes and diabetes-care
[18–20]. The strength of this approach lies in its ability to synthesize qualitative studies and
produce new interpretations, while still preserving the interpretations of the original studies.
Meta-ethnography is chosen as the best method for conducting this systematic review as it
investigates qualitative data on patient-experienced BoT.
Step 1, getting started: Relevant literature search regarding multimorbidity and BoT was
conducted with the assistance of a research librarian at the university library, and the research
questions were formulated.
Step 2, confirming initial interest: The search for relevant literature included PubMed,
Embase and PsycINFO and was done in accordance to the PRISMA guidelines[21]. The goal
of the search was to find literature on the topic”burden of treatment” combined with the
topic”multimorbidity” or the topic”general practice”. “General practice” was added to iden-
tify studies of BoT in a population recruited from general practice, likely to contain a high
proportion of patients with multimorbidity[22]. The search in PubMed was built of three
components:
1. "Burden of treatment" OR "treatment burden" OR "burden of care"
2. Multimorbid OR”comorbidity"[Mesh] OR comorbid OR”chronic disease"[Mesh]
OR”chronic disease” OR “chronic conditions" OR "chronic illness"
3. ”General practice"[Mesh] OR "general practice" OR "family practice" OR "primary care" OR
"primary health care"[Mesh] OR "primary health care" OR "primary healthcare"
The investigation included a search for the combinations of (1 AND 2) or (1 AND 3) in
June 2016. Similar search was conducted in Embase and PsycINFO.
Abstracts and titles were screened and records not concerning patients’ BoT or only smaller
parts of it, like the financial burden or polypharmacy, were excluded. Reviews and records
describing theories and models without empirical data were also excluded. This left 39 articles,
which were assessed in full text for eligibility.
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Only studies investigating self-reported BoT in a population, in which the main proportion
of the participants had multimorbidity, were included. Articles not concerning multimorbid
patients or only concerning minors, terminally ill patients or rare conditions were excluded.
Reference lists were searched to check if any substantial articles were missing, but none addi-
tional were found. Fig 1 shows the flow diagram of the search.
The quality of the included studies were assessed according to a checklist developed by Mal-
terud[23] covering aim of the study, reflexivity, methods and design, data collection and sam-
pling, theoretical framework, methods of analysis, results, discussion as well as presentation.
Step 3, reading studies and extracting data: Data, objectives, methods, theoretical perspec-
tives and working definitions of the BoT of the studies were extracted and illustrated in Tables
1 and 2.
The selection of meta-ethnography as method includes using the terms 1st order interpreta-
tions (views of the participants), 2nd order interpretations (interpretations of authors of
included studies) and 3rd order interpretations (new synthesis of 1st and 2nd order
interpretations).
To answer research question A, components of the BoT were identified from the views of
the participants in form of quotes (the 1st order interpretations) and from authors’ listings of
components. A grid was created, illustrating which studies each component was contained by,
divided in categories found suitable (Table 3).
Step 4, determining how the studies are related: The 2nd order interpretations regarding
research question B were identified in the results and discussion sections of the papers. To
answer research question C, the interpretations of the authors regarding the concept and
nature of BoT were identified in the discussion sections.
Step 5, translating the studies into one another: The 2nd order interpretations of the individ-
ual studies were compared within each research question using reciprocal translation. This
means that findings and themes from the first study were compared to findings and themes
from the second study, and individual and shared interpretations were identified. These
Fig 1. Flow diagram of the search for literature.
https://doi.org/10.1371/journal.pone.0179916.g001
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findings were thereafter compared with findings from the third study and so on. Common
conclusions were determined and both interpretations shared by multiple studies, and inter-
pretations only identified in single studies were listed. Paraphrasing of the 2nd order interpre-
tations was used to list common contributions of studies, but an effort was made to keep the
terminology from the original papers when possible.
Step 6, synthesizing translations: To develop new 3rd order interpretations the core contri-
butions of the 1st and 2nd order interpretations were identified and a “line of arguments” was
created. This means listing the new 3rd order interpretations providing a new understanding
of the BoT. The Cumulative Complexity Model was used to provide an understanding of these
interpretations.
Step 7, expressing the synthesis: The identified components of BoT were presented in the
grid (Table 3) and discussed in the text. The 2nd and 3rd order interpretations considering
question A and B were expressed in Table 4. Components, 2nd and 3rd order interpretations
were discussed in the text supplemented by 1st order interpretations in form of quotes.
Two of the included studies are based on the same interviews and focus groups (Eton et al.
and Ridgeway et al.). But as the objective and results of the studies are different and do not
overlap, both studies were included. The study conducted by Ridgeway et al. identifies factors
that mitigate the BoT and does not focus on components of the BoT as the rest of the included
studies. As a result the study is not included in the grid (Table 3).
Quality appraisal
The included studies were rated with a 0 (not satisfying),½ (partly satisfying) or 1 (satisfying)
point for each of the 29 questions in Malterud’s checklist[23]. Missing points were most often
due to lack of discussion of chosen data collection strategy, of content validity as well as
Table 1. Details of included studies.
Authors Year Country Participants QA
Who N Age
(mean)
MM Recruited from
Tran, Barnes
et al.[24]
2015 34 diffe-
rent
Adult participants with at least one chronic
condition
1053 35–57
(47)
63% 34 different mainly Western countries through
the internet
27
Sav et al.[25] 2013 Australia People with chronic conditions and their unpaid
carers
85 16–83
(57)
88% Four culturally and geographically diverse
districts
28
Noe¨l et al.[26] 2004 US Patients having two or more chronic illnesses 60 30–89 100% Eight primary care clinics within the Veterans
Health Administration—Four in large urban
metropolitan settings, four in rural communities
24,5
Eton et al.[27] 2015 US 1st round: Patients with one or more chronic
condition and complex self-care
2nd round: Diabetic, heart failure and kidney
failure patients
50 25–85
(56)
98% Mayo Clinic Rochester (specialized treatment)
and Hennepin County Medical Center
Minneapolis (large safety-net hospital)
28,5
Ridgeway et al.
[28]
28,5
Gallacher et al.
[29]
2011 UK Patients with chronic heart failure and
comorbidities
47 45–88
(73)
100% Primary care 25
Kahn et al.[30] 2014 US Low income US primary care patients with chronic
kidney disease
34 (62) >94% Two primary care (safety net) practices in
Buffalo, a low-income African-American area
which constitutes a”Health Professional
Shortage Area”
26,5
Tran, Montory
et al.[31]
2012 France Patients with at least one chronic condition 22 53–76
(70)
NA Department of internal medicine of a French
hospital and a general practitioner clinic in Paris
27,5
Bayliss et al.[32] 2003 US Adults with two or more self-reported conditions 16 31–70+
(61)
100% Urban family practices in the Carenet network
(serving disadvantaged populations) in Denver,
Colorado
26
MM = Proportion of participants with multimorbidity in %. QA = Quality assessment score. Maximum score 29 [23].
https://doi.org/10.1371/journal.pone.0179916.t001
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discussion of rivaling explanations for the findings. As it appears in Table 1, all included stud-
ies scored >24 points equal to>84% of maximum points.
Results
Included studies
Due to the inclusion criteria nine qualitative studies were included. Fig 1 shows the selection
process.
Table 2. Details of included studies.
Authors Objective Methods Theoretical perspective and working
definition of BoT
Tran,
Barnes
et al.
To describe and classify the components of
the burden of treatment for patients with
chronic conditions
Open-ended questions in an online survey in
English, French and Spanish. Content analysis
(grounded theory approach). Reinert’s
automatic textual analysis. Taxonomy, Bradley
et al.’s method
Questionnaire developed after literature
review, reviewed by seven experts.
BoT defined as “work of being a patient” on
functioning and well-being
Sav et al. To explore treatment burden among
people with a variety of chronic conditions
and comorbidities
Semi-structured interviews face to face or over
phone. Analyzed using iterative thematic
approach and constant comparison method
(grounded theory analysis)
The study was guided by the interpretive
social paradigm, described by Neuman[33].
BoT defined as consequences patients and
their families experience as a result of
undertaking or engaging in treatment
Noe¨l To explore the collaborative care needs
and preferences in primary care patients
with multiple chronic illnesses
Semi-structured interviews in focus groups.
Descriptive codes were grouped to generate
broader themes. Patterns, interrelationships
and overarching categories were discerned
among the themes
Results grouped according to Von Korff’s
collaborative management of chronic illness
care[34].
No definition of the BoT
Eton et al. To finalize a conceptual framework of
treatment burden
1st round: Semi-structured interviews in focus
groups. Used Ritchie and Lewis Framework to
create a conceptual framework
2nd round: Focus groups. To test the fitness of
the framework and clarify new issues
Normalization Process Theory[35] and prior
studies of treatment impact informed the
questions.
BoT defined as the workload of health care
and its impact on patient functioning and well-
being
Ridgeway
et al.
To present the factors that patients with
multimorbidity draw on to lessen
perceptions of treatment burden
Same as Eton et al.
Themes and subthemes were used to identify
factors that mitigate treatment burden
Same as Eton et al.
Gallacher
et al.
To assess the burden associated with
treatment among patients living with
chronic heart failure
Secondary analysis of qualitative interviews.
Ritchie and Lewis framework analysis informed
by Normalization Process Theory
Normalization Process Theory as a
conceptual tool.
BoT involves complex interactions between
factors related to health care professionals
and systems and factors related to patients’
characteristics
Kahn et al. To explore the self-management strategies
and treatment burden experienced by low
income US primary care patients with
chronic kidney disease
Semi-structured interviews one-on-one.
Inductive thematic content analysis approach
to analyze scripts and identify themes. Themes
were reorganized in light of their direct
application to Normalization Process Theory
and treatment burden
Normalization Process Theory applied to
chronic kidney disease.
Treatment burden entails the patient’s
engagement with providers, the health care
system, their family or social support network,
and personal self-care regimens
Tran,
Montory
et al.
To develop and validate an instrument for
measuring treatment burden for patients
with multiple chronic conditions
Semi-structured interviews one-on-one.
The resulting measurement instrument was
tested quantitatively on another group of
patients
Three experts highlighted topics from a
literature review. BoT defined as the impact
of healthcare on patients’ functioning and
well-being, apart from specific treatment side
effects
Bayliss To identify perceived barriers to self-care
among patients with comorbid chronic
diseases
Semi-structured interviews one-on-one. Used
Qualitative Comparative Analysis to identify
barriers to self-care
Interpreted the potential barriers to self-care
that emerged from the analysis in light of the
four components of chronic disease self-
management.
No definition of the BoT
https://doi.org/10.1371/journal.pone.0179916.t002
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Five of the included studies were conducted in the US[26–28, 30, 32]. One study was under-
taken across several, mainly Western, countries all over the world[24], while the three remain-
ing were conducted in the UK[29], Australia[25] and France[31]. The population size varied
from 16 to 1053 participants with a total number of 1367. The study populations showed varia-
tion in question of income (low/middle/high), areas (deprived in the city/wealthy/rural), eth-
nicity and age (middle-aged/older). Four studies recruited from primary care[26, 29, 30, 32].
Most studies conducted semi-structured interviews, but in a single study online questionnaires
were analyzed qualitatively[24].
Components of burden of treatment in patients with multimorbidity
The grid (Table 3) shows which components of the BoT were found in the included studies.
Patients with multimorbidity identified many different burdens in the interaction with
the healthcare system. Among these, spending time on travel and doctor visits, arranging
appointments and transportation as well as receiving contradictory advice were components
most frequently found.
Table 3. Research question A: Components of BoT found in each study.
[24] [25] [26] [27] [29] [30] [31] [32]
Interaction with the healthcare system
Spending time on travel and doctor visits x x x x x x x
Arranging appointments and transportation x x x x x x x
Receiving contradictory advice x x x x x x x
Attending multiple appointments x x x x x
Taking time off from work x x x x
Administrating paperwork x x x
Waiting to obtain treatment x x x
Communicating with healthcare providers x x x
Medication burden
Coordinating medication x x x x x x x x
Medication interfering with other activities x x x x x x
Suffering from side effects x x x x x
Feeling stigmatized because of medication x x x x
Changing or obtaining prescriptions x x x x
Using equipment or devices x x x
Lifestyle changes
Altering diet: Cutting on foods or eating more x x x x x x x
Planning and performing exercise x x x x x x x
Quitting smoking x x x
Financial burden
Paying for medication x x x x x
Paying for health insurance or consultations x x x x
Learning about
Condition and treatment x x x x x x
Navigating in the healthcare system x x
Other
Self-monitoring of health status x x x x x x x
Relationship with friends and family: Being a burden x x x x x x x
https://doi.org/10.1371/journal.pone.0179916.t003
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”For many appointments, you must leave time for: getting to the appointment, finding parking,
waiting for the appointment, seeing the doctor, getting back home. That can easily wipe out a
morning or an afternoon.”
[24]
Polypharmacy often resulted in a considerable medication burden. Patients had a hard
time coordinating their medications. Some patients used helping devices to cope with this
challenge, such as log books and dosette boxes.
“I’ve got a book and I note everything down. I note down when I’ve taken it, the dose, I note
the time, the drug, and when I’ve taken it.”
[29]
Table 4. 2nd and 3rd order interpretations of research question B and C.
Research questions 2nd order interpretations (authors’ interpretations)
Question B:
Components of BoT attracting additional
attention from patients with multimorbidi-ty
- Financial burden, lack of knowledge and the medication
burden were the components found to be mentioned most
often by patients[32]
- Diet and exercise and frequent healthcare reminding
patients of their health problem were ranked by patients as
the most burdensome components[31]
- Financial burden was most problematic for patients from
Australia and low-income patients from the US[25, 30, 32]
- Time and travel burden was particularly straining for
patients living in remote locations[25]
- The BoT was most straining when consequences of the
treatment were not immediately visible for patients[24, 30]
- Patients performed self-care tasks for conditions, in which
they had an emotional investment, at the expense of other
tasks[32]
Question C:
Conceptuali-zation of burden of treatment in
patients with multimorbidi-ty
- The BoT is described as being a multidimensional
concept, with cyclical interrelated components[25, 27]
- The BoT and the job of self-management was “hard work”
for patients[27–30]
- The work performed by the patients could be explained by
the Normalization Process Theory[28–30]
- The BoT consists of objective factors and the subjective
experience[25]
- The capacity of the patients is essential to their ability to
manage the treatment burdens[24, 27, 28, 30]
3rd order interpretations (synthesis)
Overarching synthesis - The BoT is a complex concept consisting of many
different components, interacting with each other
- The size of the experienced BoT is associated with the
workload of demands, the capacity and the context
- Socioeconomic deprived patients seemed to be more
affected by certain burdens, especially the financial and
time and travel burden
- Patients seem to prioritize and synchronize demands to
diminish the workload of the BoT
- Included studies show how patients’ capacity is
associated with their experienced BoT
- Patients mobilize and coordinate resources to improve
their ability to manage the BoT.
- Routinizing the treatment work into daily life might be a
way for patients to make workload and capacity fit together
https://doi.org/10.1371/journal.pone.0179916.t004
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Some patients felt a stigma related to taking medications while others were more concerned
with the time spent on taking medications and the interference with other activities.
”I find my whole day is full of nothing but medicine.”
[26]
In the treatment of most conditions, change of lifestyle is one of the first suggestions of the
healthcare provider. Patients were told to stop smoking, alter their diet and exercise more.
This seemed to be a challenge to many patients suffering from more than one condition.
”Yeah, they (health care providers) tell me to try exercise or walking. But sometimes, I’ll be
walking, and I be having pain in my legs.”
[27]
Learning to navigate in the healthcare system and finding information also posed a burden
for patients. Especially in the first period of time after receiving the diagnoses, patients were
burdened by the need to find information about their conditions and the treatment, not always
knowing where to find that information.
“The only information that I get. . .is when you get these tablets in box form and they try and
explain it to you . . .. Reading the leaflet, the print is that small and they use very big words for
the likes of me—it’s foreign, I don’t know what it means.”
[29]
Other components often mentioned in the studies were the financial burden, the burden
of self-monitoring of health status and the strain on relationships with friends and family.
Components of BoT attracting additional attention from patients with
multimorbidity (2nd order interpretations)
Many of the included studies identified components or areas of the BoT to stand out, attracting
additional attention from the patients in different ways. In one study the authors found the
financial burden, lack of knowledge and the medication burden to be mentioned by most
patients[32]. In another study patients were asked to rank the burden components and diet
and exercise as well as frequent healthcare reminding patients of their health problem were
ranked by patients as the most burdensome components[31].
Two of the included studies recruited participants from low-income areas in the US, and
both reported socioeconomic burden among the most straining burdens[30, 32]. Patients
found it hard to pay for public transportation, medication and insurance and to take time off
from work to go and seek medical care. One patient could not afford to buy enough medicine
for her hypertension and occasionally chose to do without it:
“Sometimes I go a month without taking it. And then I just crash and have, get dizzy, light-
headed, start getting sick, real bad headaches and stuff like that”
[30]
In many cases the amount of user charge and reimbursements from the state decided the
financial strain on the patients.
Patient-experienced burden of treatment in patients with multimorbidity
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“. . .tomorrow I’m going in to get . . . [treatment] and I don’t know how much we can claim
back on that, it won’t be very much and it costs $200”
[25]
Many patients found it necessary to obtain a private health insurance, which was hard to
afford especially for low-income earners and pensioners. Full time workers, however, experi-
enced increased absence from work and potentially decreased income because of their
treatments.
In the Australian study another group of patients were particularly exposed to the BoT[25].
Patients living in remote and rural locations experienced a considerable bigger time and travel
burden than others. The need to travel up to 3–4 hours each way made accessing specialized
care difficult. Some used their holidays from work for the travels, while others found it neces-
sary to move closer to cities with the needed treatment options.
Furthermore, the cultural background of certain patients was found to add to the BoT as
Aboriginals and Torres Strait Islanders pointed out structural racism in the healthcare system
of Australia.
Patients wanted to be active partners in their own care[26, 28]. But one of the included
studies, investigating patients with chronic kidney disease, showed that several patients didn’t
understand the mechanisms of the treatment for their kidney disease[30]. They found it easier
to comply with treatment for diseases they understood, like diabetes and hypertension, or spe-
cific approaches, like following a specific diet or exercise program. This was supported by
another study finding that the BoT was experienced as most straining to the patients, when
results or consequences of the treatment were not immediately visible[24]. The way patients
thought and felt about the treatments had a substantial importance, and individuals were
found to perform self-care tasks for conditions, in which they had an emotional investment at
the expense of other tasks[32]. Patients were especially frustrated with their treatment, when
the medication interfered with daily activities[25], while some patients felt no burden in treat-
ment components already integrated in their lives[28, 31].
Conceptualization of the burden of treatment (2nd order interpretations)
Several of the included studies described the BoT as being a multidimensional concept, as it
consisted of many different components burdening the patients. These components were
found to be interrelated and connected in a cyclical way[25, 27]. Especially the financial bur-
den had the potential to exacerbate other components, such as sticking to a diet.
“I live on vegemite sandwiches to keep my private health cover”
[25]
The included studies each had their own way to divide and categorize the components of
the BoT. Some found three or four main themes[25, 27], one study created a taxonomy[24]
and several studies fitted the components into an existing theory or model[24, 26, 29, 30].
The term”work” or”workload” was used to describe the BoT in several studies [27–30], in
which the Normalization Process Theory was used to explain how patients performed that
work and how it became embedded in everyday practice. The theory describes the work that
patients do in four constructs. Sense-making work includes learning about treatments and
their consequences. With relationship work patients engage with family members, friends or
the general practitioner to help them manage their conditions. Patients have a demanding job
on the daily basis, taking medication, attending appointments and thereby enacting work.
Patient-experienced burden of treatment in patients with multimorbidity
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Appraisal work means that patients spend time reviewing their treatment and deciding how
to regulate it.
“If I’m going on a long trip on the bus, well I never take one (furosemide) in the morning
because you have to keep going to the toilet, so if I’m going a long way, I miss the morning”
[29]
One study described the BoT as having an objective and subjective nature[25]. Objective
factors such as number of conditions and medications, health status and time to access treat-
ment were found to have an impact on the BoT, but so were factors determining the patient’s
subjective experience like the patient’s educational level, financial resources, cultural back-
ground, age, gender and employment conditions. These individual differences were found to
cause different treatment burdens for patients with similar treatment regimens.
Similar to these individual factors, several studies mentioned the capacity of the patients as
central in their ability to manage the treatment burdens[24, 27, 28, 30]. Capacity refers to the
patient’s cognitive and physical functioning, socioeconomic resources, family and social net-
work, educational levels and literacy, cultural beliefs, and other factors. Furthermore the con-
text, meaning the structure of healthcare and social support, was found important[24].
3rd order interpretations
The BoT in patients with multimorbidity shows to be a complex concept consisting of many
different components, interacting with each other. The BoT has a cyclical nature, recurring in
the Cumulative Complexity Model[13], which establishes the BoT both as a part of the work-
load but also as a feedback loop between patient health outcomes and workload.
The BoT seems to be strongly associated with the workload of treatment demands, deter-
mined by objective factors. This review shows that in order to manage this workload, some
patients occasionally discuss with their healthcare provider, what part of the treatment they
find most important. Other patients describe how they choose by themselves not to follow the
most burdening parts of the treatment. In these ways, patients seem to prioritize between treat-
ment modalities in order to synchronize demands, as described by the Cumulative Complexity
Model. This might result in some patients not following prescribed treatments, they do not
feel necessary, while other patients choose not to follow treatments they do not understand or
treatments that do not provide a visible improvement or result.
“There is stuff that I am supposed to do, and stuff that I actually do. If I did everything I am
supposed to do, my life would revolve around doctors and tests and such and there wouldn’t be
very much left for living my life. So I’ve made a bunch of choices”
[24]
The studies included in this review all agree that the patient-experienced BoT is not only
associated with the workload. Factors determining the capacity of the patients have been sug-
gested to influence the patients’ subjective experience of the BoT. Two patients with similar
diagnoses and treatments may differ in their capacity to handle their respective treatment bur-
dens. The Cumulative Complexity Model provides an understanding, as it describes patient
complexity as a balance between workload and capacity. From included studies this review has
described how deprived socioeconomic status in some cases leaves low-income patients prone
to burdens such as financial, time and travel burden. Another aspect of the capacity, the cul-
tural background, might be responsible for patients feeling exposed to structural racism, mak-
ing it harder for them to obtain healthcare.
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As described in the Cumulative Complexity Model, patients might use strategies as mobili-
zation and coordination, which might shape how capacity manifests. When patients manage
to mobilize resources, whether it is their own abilities or support from family, their ability to
handle the BoT is improved. It has been emphasized how coordination of medication is a sub-
stantial component of BoT, but coordination of resources, limitations and the environment
might also be an important job for patients in order to improve their ability to manage the
BoT. This is in alignment with the description of relationship work (cognitive participation)
derived from The Normalization Process Theory, as relationships can be used as a resource.
“I would ask my wife, like because she worked in the medical field. . .”
[30]
Interactions between workload and capacity are described in the Cumulative Complexity
Model. One of them, routinizing the treatment work into daily life seems to be a widely used
strategy for patients.
“And so I have my alarm set to remind me to take that one [medication] [. . .] because I’ll for-
get. I’ll get up and be like, okay, I gotta do this, this morning and I’ll forget. Yeah, so I set an
alarm so I always remember “
[25]
As previously described, patients felt no burden in treatment components already inte-
grated in their lives, as they had become daily routines.
Besides the capacity, another factor, the context, seems to be strongly related to the experi-
enced BoT. The structure of the healthcare system is build up differently across the countries
and in this review, patients from the US and Australia experienced a considerably bigger finan-
cial burden than patients from European countries, such as the UK and France. Other struc-
tural issues like access to specialized care and waiting time to see a doctor also seemed to be
related to the size of the BoT. Furthermore, patients living in rural locations in Australia expe-
rienced a substantial time and travel burden, as specialized care is centralized to bigger cities.
Discussion
This article is the first to systematically review and synthesize the existing qualitative data of
the BoT experienced by patients with multimorbidity. It has provided an overview of compo-
nents comprising the BoT, and of which of those components patients find to attract most
attention. Furthermore, the factors associated with which burdens patients experience as most
straining have been investigated. The BoT have been found to be a complex concept consisting
of many different components interacting with each other. Workload, capacity and context
have been shown to be associated with the size of the experienced BoT and strategies used by
patients to alter the BoT have been revealed.
Overall, the contributions of the included studies showed a strong resemblance and were
found complementary rather than conflicting. However, as seen in Table 3, none of the listed
components, except for coordination of medication, were found in all of the included studies,
and no studies contained all of the listed components. This can partly be explained by the lack
of a common definition of the BoT. Another explanation is that the studies chose different
ways to divide and present the components of the BoT.
The BoT is not static in time. “Learning about condition and treatment” was found to be an
important component in most studies, but in one study[31] patients did not consider it a part
of the BoT, as they had been living with their conditions for a long time. They had already
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adapted to it, integrated the knowledge about their conditions and treatments into the daily
life, and did not mention it during the interviews.
Strengths
Even though all included studies had the same purpose of investigating patient-experienced
BoT in multimorbidity, the studies showed great heterogeneity regarding method and theoret-
ical approach. This reflects the great complexity of this field and is seen as a strength, as the
intention of this review was not to compare, but to synthesize and extend the knowledge of the
BoT.
Another strength of this review is the great diversity among the included patients. While
having multimorbidity in common, the participants showed great variation in income, educa-
tion, origin, resident, ethnicity, cultural background and age, all adding to a broader descrip-
tion of the BoT.
The method used poses another strength. As described, the included studies approach the
concept of BoT in different ways without contradicting each other. By using meta-ethnogra-
phy, it was possible to synthesize the different approaches, descriptions and models into new
3rd order interpretations while preserving the (1st and 2nd order) interpretations of the original
studies.
All included studies did well in the quality assessment and reached medium to high quality
in the evaluation. They all scored>84% of maximum points, when rated corresponding to sat-
isfying answers to the checklist questions. One study failed to state the proportion of patients
with multimorbidity in the study population[31]. But the fact that the participants on average
consulted two different physicians and were treated with four different medications each day
indicates a high proportion of patients with multimorbidity.
Limitations
Recruitment method varied and not all studies accounted for the number of participants
invited. Patients most burdened by illness as well as treatment might not have the time and
energy to participate in voluntary research, and therefore overweight in participation of
resourceful, less burdened patients is possible. Especially one study recruited some of their par-
ticipants by advertising online and might have caused a selection of young, well-educated
patients with access to a computer and skills to use it [24]. The study gathered answers from
1053 participants using an online questionnaire. This study is in line with the others regarding
the concept of the BoT but also contributes with results showing that especially adherence
problems, drug intake and time required for healthcare tasks are great burdens for patients
with multimorbidity compared to patients with only one chronic condition.
The synthesis in this review is conducted using the Cumulative Complexity Model but
other frameworks, as the Normalization Process Theory, might as well be suitable for concep-
tualizing the BoT.
The Normalization Process Theory describes the implementation and integration of new
interventions and has shown useful to analyze and understand the BoT in stroke care[36]. It
has in several studies included in this review been used as theoretical framework describing
the patients’ treatment burden work in four constructs, as described under the 2nd order
interpretations.
Nonetheless the Cumulative Complexity Model was chosen in this review, as it was found
as the best current model for understanding our focus, explaining the complexity of the multi-
morbid patients as well as their experience of the BoT. The model has not been tested empiri-
cally, but it provides a understanding of why a certain workload from the BoT seems to affect
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some patients more than others (factors of capacity and context). Furthermore the model out-
lines several mechanisms and strategies used by the patients in the included studies to avoid
imbalance.
Relation to other studies
Demain et al. have recently conducted a systematic review of qualitative research on treatment
burden in long-term conditions[37]. They find that treatments and their total workload cause
disruptions to a person’s biological, biographical and relational capacity. This seems to agree
with findings in this review. The BoT component of “suffering from side effects” is similar to
biological disruptions. Biographical disruptions describe the loss of freedom and the negative
emotions equal to components of this review “spending time on travel and doctor visits”,
“medication interfering with other activities” and “feeling stigmatized because of medication”.
The component found in many studies included in this review, “being a burden in the rela-
tionship with friends and family”, is part of the relational disruptions described by Demain
et al.
A certain amount of concordance is expected since three of the same studies are included
in both reviews. However, Demain et al. also include studies investigating less common dis-
eases like spasmodic dysphonia and tuberculosis as well as patients in terminal phase of renal
disease of cancer. This review differs from the review of Demain et al. by focusing on patients
with multiple, mainly common, conditions, who are not in the terminal phase.
Perspectives
This review describes how patients with multimorbidity experience several burdens directly
related to their healthcare provider. Providers need to improve their ability to communicate
and to identify the individual level of the BoT. Discussing the BoT during consultations has
proven to be a challenge to doctors treating patients with diabetes[38], while especially hospi-
tal, but also primary practice, doctors treating multimorbid patients find it hard to estimate
the burden of their patients[31].
Experts have argued in favor of less disruptive treatment, ”minimally disruptive medicine,”
as a solution to the problem of an increasing BoT[39]. To identify patients who would benefit
from this approach, healthcare providers need to discuss components found in this review
with their patients, but also considerations of capacity and context of the patient are crucial.
This patient-centered care is in alignment with the “palliative approach”, which integrates val-
ues and principles from palliative care into the care of patients with chronic and potentially
life-limiting conditions[40]. The aim of this approach is to achieve the highest possible quality
of life for patients rather than focusing on the disease(s).
To help healthcare providers treat patients using these approaches, one improvement could
be an initial screening of multimorbid patients with a tool measuring the BoT, before the
beginning of a consultation. A measurement tool could also help determine which compo-
nents of the BoT that are necessary to be discussed to help the patient. Furthermore it could be
used to monitor effects of interventions on the BoT. Components found in this review could
provide a framework for developing such a tool.
Further research
Attempts to develop a tool to measure the BoT of patients with multimorbidity have already
been done. One tool has been validated in a population of participants from 27 countries[41].
Another more comprehensive tool has recently been validated in the US, the Patient Experi-
ence with Treatment and Self-management (PETS)[42] developed from data of a qualitative
Patient-experienced burden of treatment in patients with multimorbidity
PLOS ONE | https://doi.org/10.1371/journal.pone.0179916 June 23, 2017 14 / 18
study included in this review[27]. The tools include assessment of the financial burden, which
may be more relevant in certain countries than others. Nonetheless the same tool might be
used in several different countries given the strong resemblance in the BoT across the
countries.
Future research should focus on linking a quantitative measure of BoT to clinical outcomes
and investigate the outcomes of interventions. Conducting longitudinal studies of populations
of multimorbid patients is one way to do this. That kind of study design would also allow
researchers to investigate how the BoT changes over time, which no current studies show.
The capacity is a complex construct, which needs to be further explored. Work has been
done to investigate the concept of capacity experienced by multimorbid patients[43] but fur-
ther studies need to investigate the impact of the single elements of capacity on the patients’
experience of the BoT.
Conclusions
This systematic review shows that the BoT experienced by patients with multimorbidity is a
complex concept consisting of many different components interacting with each other. It is
associated with the workload of demands, the capacity and the context. Patients use strategies
such as prioritizing between treatments to diminish the workload and mobilizing and coordi-
nating resources to improve their ability to manage the BoT. Patients try to routinize and
integrate the treatment into their daily lives, which might be a way to maintain the balance
between workload and capacity.
The components of the BoT occurring in different groups of multimorbid patients in differ-
ent settings are identified. They seem to be interrelated and many components have the poten-
tial to attract additional attention from the patients. Which burden is experienced as the most
straining by the single patient seems to be related to the objective factors of the workload, the
capacity of the patient and the context. The financial burden and the time and travel burden
seem to be experienced as particularly straining to patients with deprived socioeconomic
status.
This investigation of the BoT may assist healthcare providers in facing the challenge of min-
imizing treatment burdens in patients with multimorbidity and provide a platform for further
research. Especially quantitative studies are now needed to further develop the knowledge of
the BoT.
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